Avadel Pharmaceuticals PLC Capital Reinvestment Ratio
Avadel Pharmaceuticals PLC capital reinvestment ratio. Avadel Pharmaceuticals PLC (AVDL) has a Capital Reinvestment Ratio of 0.00x as of September 2025, meaning it reinvests 0% of its operating cash flow ($23.26 Million) in capital expenditures ($10.76K). Check Avadel Pharmaceuticals PLC cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Avadel Pharmaceuticals PLC (2002–2017)
Capital reinvestment ratio of Avadel Pharmaceuticals PLC from 2002 to 2017. This chart tracks Avadel Pharmaceuticals PLC's Capital Reinvestment Ratio across 6 annual periods. Also explore AVDL net assets growth trend to track the company's year-over-year net asset growth rate.
Avadel Pharmaceuticals PLC Capital Reinvestment Ratio by Year (2002–2017)
Avadel Pharmaceuticals PLC capital reinvestment ratio by year from 2002 to 2017. For the full cash flow conversion analysis, see AVDL cash flow metrics.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2017 | 3.22x | $16.66 Million | $53.70 Million | ▲ +4972.3% |
| 2016 | 0.06x | $18.90 Million | $1.20 Million | ▲ +228.8% |
| 2015 | 0.02x | $84.29 Million | $1.63 Million | ▼ -91.1% |
| 2009 | 0.22x | $8.20 Million | $1.77 Million | ▼ -7.0% |
| 2003 | 0.23x | $12.23 Million | $2.84 Million | ▲ +42.0% |
| 2002 | 0.16x | $8.77 Million | $1.44 Million | — |